Cargando…
Why Intralesional Measles-Mumps-Rubella is Superior to Bacillus Calmette-Guérin for Treatment of Warts?
Autores principales: | Al-Qassabi, Al Mutasim, Al Kindi, Abdulrahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OMJ
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644039/ https://www.ncbi.nlm.nih.gov/pubmed/36458241 http://dx.doi.org/10.5001/omj.2022.95 |
Ejemplares similares
-
Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases
por: Al-Qassabi, Al Mutasim, et al.
Publicado: (2022) -
Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature
por: Al-Qassabi, Al-Mu’tasim, et al.
Publicado: (2022) -
Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
por: Zamanian, Abbas, et al.
Publicado: (2014) -
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022) -
Comparison of Intralesional Measles, Mumps, Rubella Vaccine and Needling in the Treatment of Recurrent Warts
por: Kolte, Surabhi R., et al.
Publicado: (2020)